FathomX
Healthcare Software · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
83 Science Park Dr 02-03/04, Singapore, ...Phone Number
+65 86613625Website
www.fathomx.coRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About FathomX
FathomX is a Digital Health AI spin-off from the National University of Singapore and National University Health System, founded by Prof Mikael Hartman and Prof Feng Meng Ling. Their flagship product, FxMammo, is an AI Assistant designed to enhance mammogram screening by reducing false positive/negative rates and improving clinical workflow efficiency. The company primarily serves the Asia Pacific region, addressing the growing demand for advanced healthcare technology. FathomX is also recognized as a portfolio company of the MedTech JUMPStart Program.Explore more
FathomX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FathomX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on FathomX recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once FathomX has new funding data
Click to see if FathomX had a recent Job posting/layoffs
Check out if FathomX is spiking on competitors!
Check if FathomX has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at FathomX
Competitive Alert! Recent activity has been detected by your competitor Masked Content
FathomX, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when FathomX launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
FathomX is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
FathomX is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about FathomX.
FathomX financials insights
Gather financial insights about FathomX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$1.6M
FathomX Tech Stack
A closer look at the technologies used by FathomX
Most Recent Scoops
Event
Events
Event
Events
Funding
Funding
FathomX News & Media
Breast Cancer AI Company FathomX Raises SGD$ 2.24 million in Pre-series A Funding
SINGAPORE, Sept. 1, 2022 /PRNewswire/ -- Singapore-based digital health AI company FathomX, a spin-off company from the National University of Singapore (NUS) and National University Health System (NUHS), recently raised a Pre-series A fund of SGD$ 2.24 million in the lead up to Series A funding. Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images including mammograms. The funding will further accelerate the
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FathomX
Sign Up For FreeTo access detailed company insights
FathomX is a Digital Health AI spin-off from the National University of Singapore and National University Health System, founded by Prof Mikael Hartman and Prof Feng Meng Ling. Their flagship product, FxMammo, is an AI Assistant designed to enhance mammogram screening by reducing false positive/negative rates and improving clinical workflow efficie... Read More
